GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tocagen Inc (NAS:TOCA) » Definitions » Other Cash Receipts from Operating Activities

Tocagen (Tocagen) Other Cash Receipts from Operating Activities


View and export this data going back to 2017. Start your Free Trial

What is Tocagen Other Cash Receipts from Operating Activities?

Other Cash Receipts from Operating Activities only applicable to companies reporting Cash Flow from Operations in direct method.


Tocagen (Tocagen) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tocagen Inc (NAS:TOCA) » Definitions » Other Cash Receipts from Operating Activities
Traded in Other Exchanges
N/A
Address
4242 Campus Point Court, Suite 500, San Diego, CA, USA, 92121
Tocagen Inc is a clinical-stage, cancer-selective gene therapy company. It is focused on developing product candidates designed to activate a patient's immune system against their own cancer from within. The company's cancer-selective gene therapy platform is built on retroviral replicating vectors, or RRVs, which are designed to selectively deliver therapeutic genes into the DNA of cancer cells. Tocagen is developing product candidate, Toca 511 and Toca FC, for the treatment of recurrent high grade glioma, or HGG, a brain cancer with limited treatment options, low survival rates and, therefore, a significant unmet medical need. Geographically, the activities are carried out through United States.